Potential Effectiveness of Chinese Patent Medicine Tongxinluo Capsule for Secondary Prevention After Acute Myocardial Infarction: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

• Main Authors: Min Li (Author), Chengyu Li (Author), Shiqi Chen (Author), Yang Sun (Author), Jiayuan Hu (Author), Chen Zhao (Author), Ruijin Qiu (Author), Xiaoyu Zhang (Author), Qin Zhang (Author), Guihua Tian (Author), Hongcai Shang (Author)
• Format: Book
• Published: Frontiers Media S.A., 2018-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Chinese patent medicine Tongxinluo capsule (TXL) is commonly used for cardio-cerebrovascular diseases. Previous research had demonstrated that TXL exhibited great clinical effects on the treatment of acute myocardial infarction (AMI), however there is a lack of systematic review. The pur...